The company manufactures and exports aluminium flat-rolled products, including coils, sheets, and alloy ingots, primarily serving the construction, automotive, and packaging industries.
The company operates in a highly cyclical and fragmented commodity market with no evidence of pricing power, as reflected by extremely thin net margins (0.4%) and low returns on capital (6.2%) that likely do not cover the cost of capital.
Earnings are primarily reinvested into working capital and maintenance of the Haldia plant, but the resulting ROE of 1.8% suggests poor value creation. The company maintains a high debt-to-equity ratio (1.69) to fund operations, which limits its flexibility.
The business succumbed to a classic commodity trap where thin margins and high leverage left no room for error. As global aluminum prices fluctuated, the company's interest coverage—already precarious at 1.36—collapsed, forcing it to prioritize debt service over essential maintenance. The 1.8% ROE proved to be a terminal signal of value destruction, as the cost of capital consistently exceeded returns. Ultimately, the lack of pricing power and the burden of a 1.69 debt-to-equity ratio led to a liquidity crunch, rendering the equity nearly worthless as the Haldia plant's output could no longer cover the fixed costs of its heavy debt load.
RichFakir rates Manaksia Aluminium Company Ltd's business quality as poor — 24/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Manaksia Aluminium Company Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Manaksia Aluminium Company Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Manaksia Aluminium Company Ltd's fair value is about ₹6 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →